Abstract
THE sequence of glucagon-like peptide-1 (7–36) amide (GLP-1) is completely conserved in all mammalian species studied, implying that it plays a critical physiological role1. We have shown that GLP-1 and its specific receptors are present in the hypo-thalamus2,3. No physiological role for central GLP-1 has been established. We report here that intracerebroventricular (ICV) GLP-1 powerfully inhibits feeding in fasted rats. ICV injection of the specific GLP-1-receptor antagonist, exendin (9-39)4, blocked the inhibitory effect of GLP-1 on food intake. Exendin (9-39) alone had no influence on fast-induced feeding but more than doubled food intake in satiated rats, and augmented the feeding response to the appetite stimulant, neuropeptide Y. Induction of c-fos is a marker of neuronal activation5. Following ICV GLP-1 injection, c-fos appeared exclusively in the paraventricular nucleus of the hypothalamus and central nucleus of the amygdala, and this was inhibited by prior administration of exendin (9-39). Both of these regions of the brain are of primary importance in the regulation of feeding6. These findings suggest that central GLP-1 is a new physiological mediator of satiety.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Orskov, C. Diabetologia 35, 701–711 (1992).
Kreymann, B. et al. Brain Res. 502, 325–331 (1989).
Kanse, S. M., Kreymann, B., Ghatei, M. A. & Bloom, S. R. FEBS Lett. 241, 209–212 (1988).
Goke, R. et al. J. biol. Chem. 268, 19650–19655 (1993).
Sagar, S. M., Sharp, F. R. & Curran, T. Science 240, 1328–1331 (1988).
Morley, J. E. Endocr. Rev. 8, 256–287 (1987).
Antin, J., Gibbs, J., Holt, J., Young, R. C. & Smith, G. P. J. comp. Physiol. Psychol. 89, 784–790 (1975).
Chow, H. L. & Beck, C. H. Eur. J. Pharmac. 102, 297–304 (1984).
Wilding, J. P. et al. J. Endocr. 132, 299–304 (1992).
Blundell, J. E., Rogers, P. J. & Hill, A. J. Brain Res. Bull. 15, 371–376 (1985).
Suzuki, S., Kawai, K., Ohashi, S., Mukai, H. & Yamashita, K. Endocrinology 125, 3109–3114 (1989).
Rai, A., Singh, G., Raffaniello, R., Eng, J. & Raufman, J. P. Am. J. Physiol 265, G118–125 (1993).
Wang, Z. et al. J. clin. Invest. 95, 417–421 (1995).
Kulkarni, R. N. et al. Reg. Pept. 57, 201 (1995).
Billington, C. J., Levine, A. S. & Morley, J. E. Am. J. Physiol. 245, R920–926 (1983).
Clark, J. T., Kalra, P. S. & Kalra, S. P. Endocrinology 117, 2435–2442 (1985).
Lambert, P. D. et al. Endocrinology 133, 29–32 (1993).
Wilding, J. P., Gilbey, S. G., Lambert, P. D., Ghatei, M. A. & Bloom, S. R. Neuroendocrinology. 57, 581–587 (1993).
Pelleymounter, M. A. et al. Science 269, 540–543 (1995).
Halaas, J. L. et al. Science 269, 543–546 (1995).
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R. & Burn, P. Science 269, 546–549 (1995).
Veale, P. R., Bhogal, R., Morgan, D. G., Smith, D. M. & Bloom, S. R. Eur. J. Pharmac. 262, 133–141 (1994).
Lambert, P. D., Phillips, P. J., Wilding, J. P. H., Bloom, S. R. & Herbert, J. Brain Res. 670, 59–65 (1995).
Arnold, F. J. et al. Neuroscience 51, 377–390 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Turton, M., O'Shea, D., Gunn, I. et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379, 69–72 (1996). https://doi.org/10.1038/379069a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/379069a0
This article is cited by
-
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings
Nature Metabolism (2024)
-
Obesity and the kidney: mechanistic links and therapeutic advances
Nature Reviews Endocrinology (2024)
-
Targeting the incretin system in obesity and type 2 diabetes mellitus
Nature Reviews Endocrinology (2024)
-
Obesogens: a unifying theory for the global rise in obesity
International Journal of Obesity (2024)
-
Pharmacokinetics and brain distribution of the therapeutic peptide liraglutide by a novel LC–MS/MS analysis
Journal of Analytical Science and Technology (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.